These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Use of OKT3 for late acute rejection in liver transplantation. Samuel D; Gugenheim J; Canon C; Saliba F; Bismuth H Transplant Proc; 1990 Aug; 22(4):1767-8. PubMed ID: 2117804 [No Abstract] [Full Text] [Related]
9. Incidence and patterns of rejection using different induction therapies in liver transplant recipients. Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835 [No Abstract] [Full Text] [Related]
10. A possible role of ursodeoxycholic acid in liver transplantation. Friman S; Svanvik J Scand J Gastroenterol Suppl; 1994; 204():62-4. PubMed ID: 7824880 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejection. Bährle S; Szabó G; Stiehl A; Theilmann L; Dengler TJ; Zimmermann R; Kübler W J Heart Lung Transplant; 1998 Jun; 17(6):592-8. PubMed ID: 9662095 [TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipients. Assy N; Adams PC; Myers P; Simon V; Ghent CN Gut; 2007 Feb; 56(2):304-6. PubMed ID: 17303606 [No Abstract] [Full Text] [Related]
14. Impact of reduced-size liver transplantation on rejection and liver allograft outcome in the pediatric population. Cacciarelli TV; So SK; Egawa H; Cox K; Esquivel CO Transplant Proc; 1995 Feb; 27(1):1239-40. PubMed ID: 7878864 [No Abstract] [Full Text] [Related]
15. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease. Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360 [No Abstract] [Full Text] [Related]
16. Use of FK 506 for treatment of chronic rejection after liver transplantation. Winkler M; Ringe B; Gerstenkorn C; Rodeck B; Gubernatis G; Wonigeit K; Pichlmayr R Transplant Proc; 1991 Dec; 23(6):2984-6. PubMed ID: 1721334 [No Abstract] [Full Text] [Related]
18. Failure of ursodeoxycholic acid to prevent acute cellular rejection after liver transplantation. Pageaux GP; Blanc P; Perrigault PF; Navarro F; Fabre JM; Souche B; Domergue J; Larrey D; Michel H J Hepatol; 1995 Aug; 23(2):119-22. PubMed ID: 7499781 [TBL] [Abstract][Full Text] [Related]
19. Treatment of acute rejection following liver transplantation: a comparison between methylprednisolone and hydrocortisone. Barron PT; Jamieson NV; Calne RY Transplant Proc; 1991 Aug; 23(4):2266. PubMed ID: 1871868 [No Abstract] [Full Text] [Related]
20. FK 506 as treatment of late acute rejection in liver transplant patients. Rucay P; Samuel D; Farges O; Reynes M; Bismuth H Transplant Proc; 1995 Feb; 27(1):1105-6. PubMed ID: 7533354 [No Abstract] [Full Text] [Related] [Next] [New Search]